In addition, the treatment with AT1 receptor antagonists attenuates cognitive impairment in a blood pressure-independent manner through reductions in blood-brain barrier permeability in Ang II- and salt-dependent hypertensive patients (Pelisch et al., 2013). The gene discussed is AGT; the disease is Cognitive impairment.